Celltrion
068270.KS
#724
Rank
A$43.69 B
Marketcap
$213.20
Share price
0.05%
Change (1 day)
0.13%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of June 2024 : A$2.51 Billion

According to Celltrion 's latest financial reports the company's total debt is A$2.51 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$0.92 B7.02%
2021-12-31A$0.86 B-6.92%
2020-12-31A$0.92 B51.51%
2019-12-31A$0.61 B-6.85%
2018-12-31A$0.65 B-14.7%
2017-12-31A$0.77 B-1.45%
2016-12-31A$0.78 B-15.93%
2015-12-31A$0.92 B-1.46%
2014-12-31A$0.94 B18.35%
2013-12-31A$0.79 B43.52%
2012-12-31A$0.55 B58.35%
2011-12-31A$0.35 B45.99%
2010-12-31A$0.24 B-0.11%
2009-12-31A$0.24 B-9.14%
2008-12-31A$0.26 B686.15%
2007-12-31A$33.66 M